{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:48:46Z","timestamp":1789753726800,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omta.2026.201786","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:41:40Z","timestamp":1781714500000},"page":"201786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["First pilot study of intrastromal rAAV-PAX6 gene therapy suggests improved corneal thickness and transcription correction in aniridic mouse"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6547-5728","authenticated-orcid":false,"given":"Sif G.","family":"Kaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-0724","authenticated-orcid":false,"given":"Tess C.","family":"Lengyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3286-9013","authenticated-orcid":false,"given":"Seyedeh Zeinab","family":"Mirjalili Mohanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9320-9764","authenticated-orcid":false,"given":"Diana","family":"Djaksigulova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-0695","authenticated-orcid":false,"given":"Andrea J.","family":"Korecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4303","authenticated-orcid":false,"given":"Elizabeth M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2026.201786_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng0892-328","article-title":"The human PAX6 gene is mutated in two patients with aniridia","volume":"1","author":"Jordan","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2026.201786_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148406","article-title":"Longitudinal genotype-phenotype analysis in 86 patients with PAX6-related aniridia","volume":"6","author":"Kit","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.omta.2026.201786_bib3","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.3390\/ijms23116115","article-title":"Thirty Years' History since the Discovery of Pax6: From Central Nervous System Development to Neurodevelopmental Disorders","volume":"23","author":"Ochi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2026.201786_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ydbio.2009.06.023","article-title":"Pax6 dosage requirements in iris and ciliary body differentiation","volume":"333","author":"Davis","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omta.2026.201786_bib5","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/hmg\/ddi231","article-title":"Genetic dissection of Pax6 dosage requirements in the developing mouse eye","volume":"14","author":"Davis-Silberman","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2026.201786_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/dvdy.21528","article-title":"PAX6 dosage effects on corneal development, growth, and wound healing","volume":"237","author":"Dor\u00e0","year":"2008","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.omta.2026.201786_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028895","article-title":"Effects of aberrant Pax6 gene dosage on mouse corneal pathophysiology and corneal epithelial homeostasis","volume":"6","author":"Mort","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201786_bib8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40123-025-01122-1","article-title":"Comprehensive Analysis of Congenital Aniridia and Differential Diagnoses: Genetic Insights and Clinical Manifestations","volume":"14","author":"Hall","year":"2025","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.omta.2026.201786_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/aos.17587","article-title":"Congenital aniridia: European COST action ANIRIDIA-NET guidelines for diagnosis, management and care","volume":"104","author":"Romano","year":"2025","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.omta.2026.201786_bib10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2026.201786_bib11","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2026.201786_bib12","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/genes10121050","article-title":"The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye","volume":"10","author":"Lima Cunha","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omta.2026.201786_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1242\/dev.02764","article-title":"Controlled overexpression of Pax6 in vivo negatively autoregulates the Pax6 locus, causing cell-autonomous defects of late cortical progenitor proliferation with little effect on cortical arealization","volume":"134","author":"Manuel","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.omta.2026.201786_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(00)80078-1","article-title":"Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities","volume":"86","author":"Schedl","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.omta.2026.201786_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201786_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071117","article-title":"Increased corneal epithelial turnover contributes to abnormal homeostasis in the pax6(+\/-) mouse model of aniridia","volume":"8","author":"Douvaras","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201786_bib17","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1167\/iovs.14-16030","article-title":"Existence of Corneal Endothelial Slow-Cycling Cells","volume":"56","author":"Espana","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201786_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-30406-4_19","article-title":"Stem cells and corneal epithelial maintenance: insights from the mouse and other animal models","volume":"55","author":"Mort","year":"2012","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.omta.2026.201786_bib19","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1167\/iovs.13-11780","article-title":"In vivo morphology of the limbal palisades of vogt correlates with progressive stem cell deficiency in aniridia-related keratopathy","volume":"54","author":"Lagali","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201786_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jtos.2017.11.003","article-title":"Stage-related central corneal epithelial transformation in congenital aniridia associated keratopathy","volume":"16","author":"Lagali","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.omta.2026.201786_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtos.2019.11.002","article-title":"Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations","volume":"18","author":"Lagali","year":"2020","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.omta.2026.201786_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ajo.2003.09.038","article-title":"Markedly increased central corneal thickness: an unrecognized finding in congenital aniridia","volume":"137","author":"Brandt","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201786_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198822","article-title":"Aniridia-related keratopathy: Structural changes in naive and transplanted corneal buttons","volume":"13","author":"Vicente","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2026.201786_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41434-018-0043-6","article-title":"Epistasis between Pax6(Sey) and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials","volume":"25","author":"Hickmott","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201786_bib25","article-title":"A human-like model of aniridia-associated keratopathy for mechanistic and therapeutic studies","volume":"10","author":"Javidjam","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.omta.2026.201786_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1167\/iovs.66.9.60","article-title":"Establishing Preclinical Quantitative Parameters for Future Assessment of Corneal and Retinal Therapeutics for Aniridia","volume":"66","author":"Kaad","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201786_bib27","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1167\/iovs.02-0576","article-title":"Corneal abnormalities in Pax6+\/- small eye mice mimic human aniridia-related keratopathy","volume":"44","author":"Ramaesh","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201786_bib28","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1167\/iovs.18-25175","article-title":"Altered Signaling Pathways in Aniridia-Related Keratopathy","volume":"59","author":"Vicente","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2026.201786_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41434-023-00400-6","article-title":"rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal limbal stem cells without lethality","volume":"30","author":"Mirjalili Mohanna","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201786_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gene.10023","article-title":"Codon-improved Cre recombinase (iCre) expression in the mouse","volume":"32","author":"Shimshek","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.omta.2026.201786_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omta.2026.201786_bib32","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/mt.2011.95","article-title":"AAV9: over the fence and into the woods","volume":"19","author":"Forsayeth","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201786_bib33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/mt.2011.72","article-title":"Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates","volume":"19","author":"Gray","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201786_bib34","article-title":"Gene Therapy for Spinal Muscular Atrophy (SMA): A Review of Current Challenges and Safety Considerations for Onasemnogene Abeparvovec (Zolgensma)","volume":"15","author":"Ogbonmide","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.omta.2026.201786_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/354522a0","article-title":"Mouse small eye results from mutations in a paired-like homeobox-containing gene","volume":"354","author":"Hill","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.omta.2026.201786_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1242\/dev.97.1.95","article-title":"Small eyes (Sey): a homozygous lethal mutation on chromosome 2 which affects the differentiation of both lens and nasal placodes in the mouse","volume":"97","author":"Hogan","year":"1986","journal-title":"Development"},{"key":"10.1016\/j.omta.2026.201786_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0016672300010387","article-title":"Small-eyes, a new dominant mutant in the mouse","volume":"9","author":"Roberts","year":"1967","journal-title":"Genet. Res."},{"key":"10.1016\/j.omta.2026.201786_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1399-0004.2006.00619.x","article-title":"Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2","volume":"69","author":"Hever","year":"2006","journal-title":"Clin. Genet."},{"key":"10.1016\/j.omta.2026.201786_bib39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ophtha.2019.09.034","article-title":"PAX6 Mutational Status Determines Aniridia-Associated Keratopathy Phenotype","volume":"127","author":"Lagali","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2026.201786_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118506","article-title":"Targeting insulin receptor substrate-1 delays disease progression in a murine model of aniridia-associated keratopathy","volume":"191","author":"Dashti","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omta.2026.201786_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.08.042","article-title":"LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea","volume":"350","author":"Mirjalili Mohanna","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.omta.2026.201786_bib42","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.3390\/jcm11164717","article-title":"Subretinal Injection Techniques for Retinal Disease: A Review","volume":"11","author":"Irigoyen","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.omta.2026.201786_bib43","first-page":"142","article-title":"First pilot study of intravenous rAAV-PAX6 gene therapy increases retinal-ganglion-cell-layer thickness and Notch1 transcription in a mouse model of aniridia","volume":"33","author":"Djaksigulova","year":"2026","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201786_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/cells15040324","article-title":"Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology","volume":"15","author":"Skorkina","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.omta.2026.201786_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2016.04.017","article-title":"PAX6: 25th anniversary and more to learn","volume":"156","author":"Cvekl","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omta.2026.201786_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3436415","article-title":"A Combination of Intrastromal and Intracameral Injections of Amphotericin B in the Treatment of Severe Fungal Keratitis","volume":"2016","author":"Hu","year":"2016","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.omta.2026.201786_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/S0004-27492012000400012","article-title":"Intrastromal injection of bevacizumab in patients with corneal neovascularization","volume":"75","author":"Vieira","year":"2012","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.omta.2026.201786_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.omtm.2020.03.002","article-title":"Germline CRISPR\/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia","volume":"17","author":"Mirjalili Mohanna","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2026.201786_bib49","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1089\/hum.2018.115","article-title":"Sustained and widespread gene delivery to the corneal epithelium via in situ transduction of limbal epithelial stem cells using lentiviral and AAV vectors","volume":"29","author":"Basche","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2026.201786_bib50","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/ph18091352","article-title":"Genetic Basis of Non-Syndromic Childhood Glaucoma Associated with Anterior Segment Dysgenesis: A Narrative Review","volume":"18","author":"Cronbach","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omta.2026.201786_bib51","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s40123-023-00729-6","article-title":"ABE8e Corrects Pax6-Aniridic Variant in Humanized Mouse ESCs and via LNPs in Ex Vivo Cortical Neurons","volume":"12","author":"Adair","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.omta.2026.201786_bib52","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.ymthe.2023.03.035","article-title":"Ocular stress enhances contralateral transfer of lenadogene nolparvovec gene therapy through astrocyte networks","volume":"31","author":"McGrady","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2026.201786_bib53","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omta.2026.201786_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106681","article-title":"Retinal damage promotes mitochondrial transfer in the visual system of a mouse model of Leber hereditary optic neuropathy","volume":"201","author":"Ezan","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2026.201786_bib55","first-page":"1076","article-title":"Selection of housekeeping genes for use in quantitative reverse transcription PCR assays on the murine cornea","volume":"16","author":"Ren","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.omta.2026.201786_bib56","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/gtc.12254","article-title":"Stage-specific reference genes significant for quantitative PCR during mouse retinal development","volume":"20","author":"Adachi","year":"2015","journal-title":"Genes Cells"},{"key":"10.1016\/j.omta.2026.201786_bib57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4252\/wjsc.v6.i4.391","article-title":"Limbal stem cells: Central concepts of corneal epithelial homeostasis","volume":"6","author":"Yoon","year":"2014","journal-title":"World J. Stem Cell."},{"key":"10.1016\/j.omta.2026.201786_bib58","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.celrep.2014.07.051","article-title":"Cell-Autonomous Repression of Shh by Transcription Factor Pax6 Regulates Diencephalic Patterning by Controlling the Central Diencephalic Organizer","volume":"8","author":"Caballero","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.omta.2026.201786_bib59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ydbio.2006.08.035","article-title":"Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies cortical cell identity by a cell autonomous mechanism","volume":"302","author":"Quinn","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omta.2026.201786_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1749-8104-2-2","article-title":"Direct non-cell autonomous Pax6 activity regulates eye development in the zebrafish","volume":"2","author":"Lesaffre","year":"2007","journal-title":"Neural Dev."},{"key":"10.1016\/j.omta.2026.201786_bib61","article-title":"Eyeless\/Pax6 initiates eye formation non-autonomously from the peripodial epithelium","volume":"145","author":"Baker","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.omta.2026.201786_bib62","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/s41598-018-20421-1","article-title":"Retinal progenitor cells release extracellular vesicles containing developmental transcription factors, microRNA and membrane proteins","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201786_bib63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.11604\/pamj.2020.35.52.20225","article-title":"Intrastromal injection of voriconazole as a therapeutic of fungal hypopyon: a case report","volume":"35","author":"Albab","year":"2020","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.omta.2026.201786_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng0293-170","article-title":"X-chromosome inactivation occurs at different times in different tissues of the post-implantation mouse embryo","volume":"3","author":"Tan","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2026.201786_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79004-y","article-title":"New MiniPromoter Ple389 (ADORA2A) drives selective expression in medium spiny neurons in mice and non-human primates","volume":"14","author":"de Moura Gomes","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2026.201786_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41434-021-00227-z","article-title":"Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, M\u00fcller glial, and PAX6 cells","volume":"28","author":"Korecki","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.omta.2026.201786_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13041-016-0232-4","article-title":"rAAV-Compatible MiniPromoters for Restricted Expression in the Brain and Eye","volume":"9","author":"de Leeuw","year":"2016","journal-title":"Mol. Brain"},{"key":"10.1016\/j.omta.2026.201786_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.51","article-title":"PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina","volume":"3","author":"Hickmott","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X26001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:18:43Z","timestamp":1789053523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X26001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3117387X26001217"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2026.201786","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First pilot study of intrastromal rAAV-PAX6 gene therapy suggests improved corneal thickness and transcription correction in aniridic mouse","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2026.201786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201786"}}